Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Poultry Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app


Collect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Poultry Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Sponsored By Zoetis


Mountaire veterinarian discusses managing E. coli in broilers in the face of IBV infection

During the winter of 2015, broiler producers on the Delmarva Peninsula were hit with a new infectious bronchitis variant, Delmarva 1639.

Without an effective vaccine for that IB variant, poultry producers focused on controlling the secondary infection, Escherichia coli, in an attempt to reduce mortality and production losses.

 “The losses were widespread with all five of the major producers seeing mortality rates of 10% and condemnations at twice the national average,” Don Ritter, DVM, of Mountaire Farms told Poultry Health Today.

Cold weather, decreased ventilation and increased ammonia levels compounded the stress on the birds, providing an opportunity for E. coli to add to the birds’ pathology. Any disease that challenges the respiratory or immune system opens the door for E. coli.

“Once infectious bronchitis damages the cilia in the trachea, E. coli moves in,” Ritter said. The secondary E. coli infection led to higher levels of exudative pathology in the birds and more condemnations due to lesions in addition to the high mortality levels.

In an effort to reduce mortality levels, and without an effective IB vaccine, producers began vaccinating for E. coli.

“The only thing we really had going for us in terms of control was the vaccine,” Ritter said. “We found in the houses with high mortality levels, it really helped. We still had high levels of condemnations, but the vaccine paid for itself in reduced mortality.”

With warmer weather, increased ventilation and lower ammonia levels, the IB threat subsided. “We saw our mortality levels drop as we moved into spring but our condemnation levels due to E. coli remained higher than normal into summer,” Ritter said.

Secondary E. coli infections frequently occur following damage to the respiratory system from IB, Newcastle disease or an immune-system challenge.

For the winter of 2016, Delmarva broiler producers are looking to a new IB vaccine for cross protection. In addition, they are conducting an intense trial of E. coli vaccinations every 2 of 3 weeks in the coldest months.

For more on Mountaire’s experience, watch the video of the interview.




Posted on April 7, 2016

tags: , , , , , , , ,

You must be logged in to edit your profile.

Share It
The complementary effect of two new vaccines provides immunity against infectious bursal disease virus (IBDV) – one of the major threats to commercial flocks worldwide.

Click an icon to share this information with your industry contacts.
Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.